Abstract
In Chapter 26, the requirements of an ideal lithium preparation have been outlined, and the question naturally arises as to which of the many lithium preparations currently available most nearly conforms to the criteria enunciated in that chapter. This question is not, unfortunately, one which is easily answered.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Johnson, F. N. and Johnson, S. (eds.) (1977). Clinical Trials. Blackwell Scientific Publications: Oxford.
Chambers, D. R. (1970). Legal considerations in drug evaluation. In Harris, E. L. and Fitzgerald, J. D. (eds.) The Principles and Practice of Clinical Trials. Livingstone: Edinburgh, pp. 31–36.
Coppen, A., Bailey, J. E. and White, S. G. (1969). Slow release lithium carbonate.J. Clin. Pharmacol., 9, 160–162.
Crammer, J. L., Rosser, R. M. and Crane, G. (1974). Blood levels and management of lithium treatment. Br. Med. J., 2, 650–654.
Caldwell, H. C., Westlake, W. J., Connor, S. M. and Flanagan, T. (1971). A pharmacokinetic analysis of lithium carbonate absorption from several formulations in man.J. Clin. Pharmacol., 11, 349–356.
Persson, G. (1974). Plasma lithium levels and side effects during administration of a slow release lithium sulphate preparation (Lithium Lipett C) and lithium carbonate tablets. Acta Psychiat. Scand., 50, 174–182.
Tyrer, S., Hullin, R. P., Birch, N. J. and Goodwin, J. C. (1976). Absorption of lithium following administration of slow-release and conventional preparations. Psychol. Med., 6, 51–58.
Bennie, E. H., Manzoor, A. K. M., Scott, A. M. and Fell, G. S. (1977). Serum concentrations of lithium after three proprietary preparations of lithium carbonate (Priadel, Phasal and Camcolit). Br. J. Clin. Pharmacol., 4, 479–483.
Marini, J. L. and Sheard, M. H. (1976). Sustained-release lithium carbonate in a double-blind study: serum lithium levels, side effects, and placebo response. J. Clin. Pharmacol., 16, 276–283.
Tyrer, S. P. (1977). The choice of lithium preparation and how to give it. In Johnson, F. N. and Johnson, S. (eds.) Lithium in Medical Practice. MTP Press: Lancaster, pp. 395–405.
Tyrer, S. P. (1977). Bioavailability of lithium preparations. Paper presented at VIth World Congr. Psychiatry, Honolulu. Abstracts p. 140.
Thornhill, D. P. (1978). Pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients after acute dosage. Eur. J. Clin. Pharmacol., 14, 267–271.
Cooper, T. B., Simpson, G. M., Lee, J. H. and Bergner, P-E. E. (1978). Evaluation of a slow-release lithium carbonate formulation. Am. J. Psychiat., 135, 917–922.
Amdisen, A. (1975). Monitoring of lithium treatment through determination of lithium concentration. Dan. Med. Bull., 22, 277–291.
Jeppsson, J. and Sjögren, J. (1975). The influence of food on side effects and absorption of lithium. Acta Psychiat. Scand., 51, 285–288.
Amdisen, A. (1975). Sustained release preparations of lithium. In Johnson, F. N. (ed.) Lithium Research and Therapy. Academic Press: London, pp. 197–210.
Scott, M. R. (1977). Absorption of lithium from controlled release preparations. Br. Med. J. 1, 1533.
Poust, R. I., Mallinger, A. G., Mallinger, J., Himmelhoch, J. M., Neil, J. F. and Hanin, I. (1977). Absolute availability of lithium. J. Pharm. Sci., 66, 609.
Amdisen, A. and Sjögren, J. (1968). Lithium absorption from sustained release tablets (Duretter). Acta Pharm. Suecica, 5, 465–472.
Grof, P., MacCrimmon, D., Saxena, B., Daigle, L and Prior, M. (1976). Bioavailability and side effects of different lithium carbonate products. Neuropsychobiol., 2, 313–323.
Wall, B. P., Parkin, J. E. and Sunderland, V. B. (1978). A review of the bioavailability of lithium from its dosage forms. Aust. J. Pharm. Sci., 7, 57–59.
Laurell, B. and Persson, G. (1970). Biverkningar vid profylaktisk lithiumbe-handling-en jämförelse mellan två beredningsformer. Läkartid., 67, 3083–3085.
Fyrö, B., Pettersson, U. and Sedvall, G. (1970). Serum lithium levels and side effects during administration of lithium carbonate and two slow release preparations to human volunteers. Psychopharmacol Clin., 2, 236–240.
Persson, G. (1971). Side effects of a ‘sustained release’ lithium preparation. Acta Psychiat. Scand., Suppl. 221, 33–38.
Borg, K. O., Jeppsson, J. and Sjögren, J. (1974). Influence of the dissolution rate of lithium tablets on side effects. Acta Pharmaceut. Suecica, 11, 133–140.
Amdisen, A. (1969). Variations of serum lithium concentrations during the day in relation to treatment control, absorptive side effects and the use of slow-release tablets. Acta Psychiat. Scand., Suppl. 207, 55–57.
Consbruch, U. and Koufen, H. (1972). Zur Pharmakokinetik von Lithiumsalzen bein akuten Belastungsversuchen Gesunder. Pharmakopsych. Neuro-Psychiat., 5, 3–11.
Matussek, N. and Von Hessling, P. (1971). Vergleich von Lithium-Nebenwirkungen zwischen einem Kurzzeit (Quilonum) und einem Depotpräparat (Lithium Duriles). Nervenarzt, 42, 376–378.
Nieper, H. A. (1973). The clinical applications of lithium orotate. A two years study. Aggressologie, 14, 407–411.
Smith, D. F. (1976). Lithium orotate, carbonate and chloride: pharmacokinetics, polydipsia and polyuria in rats. Br. J. Pharmacol., 56, 399–402.
Kling, M. A., Manowitz, P. and Pollack, I. W. (1978). Rat brain and serum lithium concentrations after acute injections of lithium carbonate and orotate. J. Pharm. Pharmacol., 30, 368–370.
Heiman, M. F., Schwabach, G. and Tupin, J. (1976). Liquid lithium vs. solid lithium: an open, cross-over, pilot study comparing oral preparations. Dis. Nerv. Syst., 37, 9–11.
Sugita, E. T., Stokes, J. W., Frazer, A., Grof, P., Mendels, J., Goldstein, F. J. and Niebergall, P. J. (1973). Lithium carbonate absorption in humans.J. Clin. Pharmacol., 13, 264–270.
Poitu, P. and Bohoun, C. (1974). Erythrocytes, and brain lithium concentrations in the rat after a single oral administration of different salts.J. Pharmacologie, Suppl. 1, 79.
Altamura, A. C., Gomeni, R., Sacchetti, E. and Smeraldi, E. (1977). Plasma and intracellular kinetics of lithium after oral administration of various lithium salts. Eur. J. Clin. Pharmacol., 12, 59–63.
Shaw, D. M., Hewland, R., Johnson, A. L. and Howlett, M. R. (1974). Comparison of serum levels of two sustained release preparations of lithium carbonate. Curr. Med. Res. Opin., 2, 90–94.
Hullin, R. P. (1977). Absorption of lithium from controlled-release preparations. Br. Med. J., 1, 1349.
Burton, P. (1975). Expérimentation clinique d’un carbonate de lithium retard. Rev. Med. Liege, 30, 79–80.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 MTP Press Limited
About this chapter
Cite this chapter
Johnson, F.N. (1980). The Choice of an Appropriate Lithium Preparation. In: Johnson, F.N. (eds) Handbook of Lithium Therapy. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-7197-7_27
Download citation
DOI: https://doi.org/10.1007/978-94-011-7197-7_27
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-011-7199-1
Online ISBN: 978-94-011-7197-7
eBook Packages: Springer Book Archive